More importantly, CLU KD enhanced cisplatin-induced cytotoxicity as indicated by lower cell viability, which was reversed in CLU-overexpressing oral cancer cells during cisplatin treatment (Figure 1J-K). This evidence concerns the gene CLU and lip and oral cavity carcinoma.